1.
Open Forum Infect Dis
; 9(8): ofac377, 2022 Aug.
Artículo
en Inglés
| MEDLINE
| ID: mdl-35949403
RESUMEN
A large, ongoing multicountry outbreak of human monkeypox has the potential to cause considerable morbidity and mortality. Therapeutics for the treatment of smallpox, a related Orthopoxvirus, may be used and affect the natural history of monkeypox. We present 3 patients from our hospitals treated with tecovirimat, a pan-Orthopoxvirus inhibitor currently available under an expanded access investigational new drug protocol for monkeypox.